Tourette syndrome. Medical and surgical treatment of obsessive-compulsive disorder (Q41441913)

30 September 2017

1 reference

title

Tourette syndrome. Medical and surgical treatment of obsessive-compulsive disorder (English)

1 reference

obsessive-compulsive disorder

30 September 2017

1 reference

Rapoport JL

1

1 reference

PubMed ID

9115472

30 September 2017

Inoff-Germain G

series ordinal

2

1 reference

30 September 2017

1 May 1997

1 reference

30 September 2017

1 reference

30 September 2017

15

1 reference

30 September 2017

2

1 reference

30 September 2017

421-428

1 reference

Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Oxytocin in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Oxytocin — A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

D-amphetamine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Neurological factors in obsessive compulsive disorder. Two case reports and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

"Just right" perceptions associated with compulsive behavior in Tourette's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

A family study of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Neurosurgical treatment of Tourette's syndrome: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

Intravenous chlorimipramine therapy in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970323-6

7 January 2021

10.1016/S0733-8619(05)70323-6

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9115472